Cigna Corp.

What's your position on ?
Why are you ish?
You voted ish on Vote again
Posts appear on the My Feed page of subscribers to this ticker
Last vote:
  • Feb. 6, 2014, 5:30 PM
  • Dec. 11, 2013, 12:08 PM
    • "Any hopes of a roll-back of the 2% Medicare sequestration cuts were dashed as more details of the plan were revealed over the course of the evening," Deutsche's Scott Fidel notes, referencing the new U.S. budget agreement.
    • "In fact," Fidel continues, "under the budget deal the 2% Medicare payment cuts will actually be extended by two years through 2023."
    • Nevertheless, Deutsche doesn't think anyone was expecting much in the way of a roll-back anyway, and as such, the bank sees limited impact for MCO names.
    | Dec. 11, 2013, 12:08 PM
  • Nov. 25, 2013, 3:40 PM
    • "Because the President is looking for MCOs to work with the Administration in smoothing out the transition to the ACA, there is increasing investor perception that the sector may be to obtain some concessions in exchange for its help," UBS' A.J. Rice says, in a note on the managed care space.
    • Rice likes Aetna (AET +1.2%) and Cigna (CI +1.4%) based on "strong visibility on future growth, limited ACA exposure, [and] company specific catalysts," while UnitedHealth (UNH +0.3%) is also Buy-rated.
    • Price targets: AET, $82 (from $76); UNH, $84 (from $81); ELP $98 (from $87); HUM $95 (unchanged).
    | Nov. 25, 2013, 3:40 PM
  • Nov. 21, 2013, 9:29 AM
    • Aetna (AET) initiated at Overweight by Morgan Stanley. Price target is $83.
    • WellPoint (WLP) initiated at Equalweight by Morgan Stanley. See also: WLP to reaffirm guidance.
    • Cigna (CI) started at Overweight by Morgan Stanley. Price target is $100.
    • Humana (HUMstarted at Equalweight at Morgan Stanley.
    • Sorrento Therapeutics (SRNE) started at Buy at CRT Capital. Price target is $11.
    • Cardinal Health (CAH) initiated at Hold at Deutsche Bank. Price target is $66.
    • Charles River Labs (CRL) started at Hold at Deutsche Bank. Price target is $55.
    • althenahealth (ATHN) started at Buy at Deutsche Bank. Price target is $162.
    • UnitedHealth (UNH) started at Overweight at Morgan Stanley. Price target is $84.
    • Centene (CNC) started at Equalweight at Morgan Stanley.
    • Amicus Therapeutics (FOLD) cut to Neutral from Buy at Janney. Price target is now $2.50. See also: FOLD revises terms of Glaxo deal, outlines acquisition, financing.
    | Nov. 21, 2013, 9:29 AM
  • Nov. 21, 2013, 4:34 AM
    • President Barack Obama might have said that consumers will be allowed to keep canceled health-insurance policies for one more year, but at least five states - including New York and Washington - won't let such plans be reinstated, as they believe it would harm their exchanges.
    • Many carriers are also not allowing their customers to extend their old policies, due to time constraints and other obstacles. And those firms that may reverse the cancellations have said that premiums could rise.
    • Of the major players, Cigna (CI) could reinstate policies, while WellPoint (WLP) is analyzing the situation.
    • More on Obamacare.
    • Relevant company tickers: AET, HNT, MOH, HUM, UNH
    | Nov. 21, 2013, 4:34 AM | 5 Comments
  • Nov. 17, 2013, 3:00 AM
    • Aetna (AET) CEO Mark Bertolini was among 15 insurance chiefs who met with President Obama and reportedly expressed concern about his one-year reprieve for people whose policies were canceled because the plans didn't meet the requirements of the healthcare law.
    • The fear is that the move will make it more difficult to attract the healthy customers who are seen as critical to the success of Obamacare.
    • The CEOs at the meeting included those of Cigna (CI), WellPoint (WLP), Health Net (HNT) and Molina Healthcare (MOH).
    • The meeting came after Congress passed a bill that would allow people to keep their existing policies through 2014. While the measure received strong Democrat support, it won't advance in the Senate, although members of the latter chamber have proposed similar legislation.
    | Nov. 17, 2013, 3:00 AM | 12 Comments
  • Nov. 12, 2013, 4:46 AM
    • Fewer than 50,000 people had managed to enroll in private insurance plans via the government's problem-plagued Web site as of last week. The number represents less than 10% of the 500,000 people that had been projected.
    • Twelve of the 14 states that are operating their own exchanges have signed up 49,000. The total is therefore also well below the initial target, which was 800,000. The Congressional Budget Office's prediction of 7M enrollments by March seems like a distant dream.
    • Major health insurers are so concerned that they want to be allowed to sign up those who are entitled to subsidies directly rather than via the federal system. However, the administration isn't keen, due to privacy concerns.
    • Insurers: Aetna (AET), WellPoint (WLP), UnitedHealth Group (UNH), Humana (HUM), Cigna (CI), Molina Healthcare (MOH).
    | Nov. 12, 2013, 4:46 AM | 2 Comments
  • Nov. 5, 2013, 9:26 AM
    • Monness Crespi is out with downgrades for health insurers.
    • Aetna (AET), Cigna (CI), WellPoint (WLP), UnitedHealth (UNH), and Humana (HUM) are all cut to Neutral from Buy.
    • Most of the names are trading fairly close to their respective 52-week highs.
    • % below 52-week highs as of Monday's close: WLP -3.5%, AET -8%, CI -6%, UNH -9%, HUM -5.7%
    | Nov. 5, 2013, 9:26 AM
  • Oct. 31, 2013, 9:42 AM
    • Shares of Cigna (CI +5%) rally as Q3 results top estimates.
    • Revenues rise 10% Y/Y in Q3, while adjusted income from operations jumps 12%.
    • Premiums and fees growth by segment: Global Health Care, +7%; Global Supplemental Benefits, +29%; Group Disability and Life, +9%.
    • FY13 outlook: $6.70-6.90/share versus previous guidance of $6.25-6.65/share and against consensus of $6.65. (PR)
    | Oct. 31, 2013, 9:42 AM
  • Oct. 31, 2013, 6:05 AM
    • CIGNA (CI): Q3 EPS of $1.89 beats by $0.26.
    • Revenue of $8.1B (+10% Y/Y) beats by $0.87B. (PR)
    | Oct. 31, 2013, 6:05 AM
  • Oct. 31, 2013, 12:05 AM
  • Oct. 30, 2013, 5:30 PM
    | Oct. 30, 2013, 5:30 PM | 2 Comments
  • Oct. 28, 2013, 5:12 AM
    • The Affordable Care Act appears to have so far proved beneficial to investors in health insurers.
    • Over the past year, the share prices of the five top firms in the sector — Aetna (AET), WellPoint (WLP), UnitedHealth Group (UNH), Humana (HUM) and Cigna (CI) — have increased an average of 32%, well above the S&P 500's rise of 24%.
    • Health insurers predict that their earnings will rise after Obamacare is fully in effect, as they expect to gain more customers from people being forced to buy coverage. This is seen offsetting the cost of increased regulations. A fall in healthcare costs has also helped the sector.
    | Oct. 28, 2013, 5:12 AM
  • Aug. 28, 2013, 10:19 AM
    • The Department of Health & Human Services (HHS) has reportedly delayed the signing of final agreements with insurance plans that are to be sold on health insurance exchanges starting on October 1.
    • The HHS intends to sign the plans - which are a crucial part of Obamacare - in mid-September rather than from September 5-9, as previously intended. The reasons for the delay aren't clear.
    • The HHS says it's "on track to open" the marketplaces on time on October 1, although the delay raises doubts about whether that's the case.
    • "Having everything ready on October 1 is not a critical issue," says an administration official who worked on Obamacare. "What matters to people is January 1, which is when the coverage is supposed to start. If that were delayed, it would be a substantive setback.
    • Related tickers: AET, UNH, HNT, CI, WLP, UAM, HUM, MOH, CNC, CVH, MGLN
    | Aug. 28, 2013, 10:19 AM | 2 Comments
  • Aug. 19, 2013, 7:21 AM
    • Cigna (CI) will require that patients receive counseling before it will pay for genetic tests for certain cancers and other diseases.
    • The decision affects checks for the BRCA1 and BRCA2 genes, a leading cause of hereditary breast cancer, and genes for colon cancer and a heart abnormality called long QT syndrome
    • The requirement could particularly affect Myriad Genetics (MYGN) - 85% of its $613.2M revenue in the last fiscal year came from BRCA tests. Counselors may decide that women need alternative tests not provided by Myriad, or that they don't need to be checked at all.
    | Aug. 19, 2013, 7:21 AM
  • Aug. 15, 2013, 3:22 PM
    • Many health insurers are gearing up to limit the choices of doctors and hospitals they'll cover. Why? The cost.
    • Smaller networks of providers generally translate to lower premiums, because insurers can negotiate discounts with health-care providers who will then have less competition for patients within the network.
    • Insurers are betting that consumers who buy plans on the exchanges will be willing to trade some choice and flexibility in order to get cheaper premiums.
    • The backlash is that consumers will generally have to pay the cost out of his own pocket if they want to see physicians outside the system.
    | Aug. 15, 2013, 3:22 PM | 6 Comments
Company Description
Cigna Corp is a health services organization with insurance subsidiaries that are providers of medical, dental, disability, life and accident insurance and related products and services.
Sector: Healthcare
Country: United States